Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Background Observational studies showed that the profile of infective endocarditis (IE) significantly changed over the past decades. However, most studies involved referral centers. We conducted a population-based study to control for this referral bias. The objective was to update the description of characteristics of IE in France and to compare the profile of community-acquired versus healthcare-associated IE. Methods A prospective population-based observational study conducted in all medical facilities from 7 French regions (32% of French individuals aged ≥18 years) identified 497 adults with Duke-Li-definite IE who were first admitted to the hospital in 2008. Main measures included age-standardized and sex-standardized incidence of IE and multivariate Cox regression analysis for risk factors of in-hospital death. Results The age-standardized and sex-standardized annual incidence of IE was 33.8 (95% confidence interval [CI], 30.8-36.9) cases per million inhabitants. The incidence was highest in men aged 75-79 years. A majority of patients had no previously known heart disease. Staphylococci were the most common causal agents, accounting for 36.2% of cases (Staphylococcus aureus, 26.6%; coagulase-negative staphylococci, 9.7%). Healthcare-associated IE represented 26.7% of all cases and exhibited a clinical pattern significantly different from that of community-acquired IE. S. aureus as the causal agent of IE was the most important factor associated with in-hospital death in…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other studies [6][7][8] suggest that the risk of neurological deterioration during cardiac surgery after a stroke is lower than previously assumed, particularly in patients with silent cerebrovascular emboli.”
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742 · cited 1×
“residence, dates of first symptoms and first hospitalization, transfer from/to another facility, history of heart disease, comorbidities (including diabetes mellitus, cancer, dialysis, and immunosuppressive therapy), Charlson comorbidity index [13], procedures and other risk factors for IE, signs and symptoms of IE, e…”
BackgroundBurden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881 · cited 1×
“First, the decrease in rheumatic heart disease and the increase in degenerative heart diseases have led to an increase in patients’ age and frequency of comorbidities [2, 3].”
BackgroundProposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027 · cited 1×
“This process also included the validation of the diagnosis according to the Duke criteria modified by Li [20].”
MethodIung, B. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00201-x · Cited by 3,530 · cited 2×
“First, the decrease in rheumatic heart disease and the increase in degenerative heart diseases have led to an increase in patients’ age and frequency of comorbidities [2, 3].”
BackgroundSelf-citationMurdoch, D. R. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.603 · Cited by 2,362 · cited 3×
“pathogens in cases of IE [9]; these findings were later confirmed by different observational studies [1, 6].”
BackgroundResultSelf-citationFriedman, N. D., Kaye, K. S., Stout, J. E., McGarry, S. A., Trivette, S. L., Briggs, J. P., Lamm, W., Clark, C., MacFarquhar, J., Walton, A. L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00007 · Cited by 1,668 · cited 1×
“The mode of IE acquisition was categorized on the basis of 3 mutually exclusive classes: (1) injection drug use–associated IE, (2) community-acquired IE, and (3) healthcare-associated IE, which included nosocomial and nonnosocomial IE, according to prior definitions [6, 14–16] described in detail in the supplementary…”
MethodStaphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174 · cited 6×
“aureus IE study by Fowler et al [6].”
BackgroundMethodResultInfluentialSelf-citationJarraud, S., Mougel, C., Thioulouse, J., Lina, G., Meugnier, H., Forey, F., Nesme, X., Etienne, J., & Vandenesch, F. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.631-641.2002 · Cited by 1,151 · cited 1×
“Microbiologists were asked to send all strains of streptococci and staphylococci to the corresponding national reference centers, where identification was confirmed on the basis of phenotypic and molecular microbiology techniques [17–19].”
BackgroundSelf-citationChanging Profile of Infective Endocarditis<SUBTITLE>Results of a 1-Year Survey in France</SUBTITLE>
Hoen, B. (2002) · JAMA · doi:10.1001/jama.288.1.75 · Cited by 987
Self-citationMoreillon, P., & Que, Y.-A. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15266-x · Cited by 861
Research works printed but not linked: 1
- 2002, Changing profile of infective endocarditis: results of a one-year survey in France in 1999, JAMA, 288, 75
Cited by
Items 301–400 of 790
Infective Endocarditis during Pregnancy—Keep It Safe and Simple!
Aursulesei, V. O., Adam, C. A., Marcu, D. T. M., Crișan-Dabija, R. A., Ceasovschih, A., Constantin, M., Grigorescu, E.-D., Petroaie, A. D., & Mitu, F. (2023) · Medicina · doi:10.3390/medicina59050939 · Cited by 12
Case conferences for infective endocarditis: A quality improvement initiative
Tan, C., Hansen, M. S., Cohen, G. N., Boyle, K., Yang, A., Rishu, A. H., Pinto, R. L., Adhikari, N. K. J., & Daneman, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205528 · Cited by 12
Epidemiology of Infective Endocarditis
Vallejo, F. A. G. (2016) · InTech eBooks · doi:10.5772/65030 · Cited by 12
“Staphylococcus aureus has surpassed penicillin-sensitive Streptococci as the most common cause in many high-income countries [10].”
BackgroundKinney, K. J., Stach, J. M., Kulhánková, K., Brown, M., & Salgado‐Pabón, W. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.925914 · Cited by 12
hVISA and MRSA endocarditis: an 8-year experience in a tertiary care centre
Maor, ., Belausov, N., Ben-David, D., Smollan, G., Keller, N., & Rahav, G. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12498 · Cited by 12
Infective endocarditis: a retrospective cohort study
O'Connor, C. T., O’Rourke, S., Buckley, A., Murphy, R. T., Crean, P., Foley, B., Maree, A. O., Ryan, R. J., Tolan, M. J., Young, V., et al. (2019) · QJM · doi:10.1093/qjmed/hcz134 · Cited by 12
Durante‐Mangoni, E., Giuffrè, G., Ursi, M. P., Iossa, D., Bertolino, L., Senese, A., Pafundi, P. C., D’Amico, F., Albisinni, R., & Zampino, R. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.08.011 · Cited by 12
The use of allogenic and autologous tissue to treat aortic valve endocarditis
Nappi, F., Singh, S., Lusini, M., Nenna, A., Gambardella, I., & Chello, M. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.08.76 · Cited by 12
“In high-income countries, the majority of patients undergoing AVR for IE are elderly (4,5), so surgery of infective aortic valve disease is recommended using bioprosthetic valves (21).”
BackgroundEthnic disparities in the incidence of infective endocarditis in the Pacific
Mirabel, M., André, R., Barsoum, P., Colboc, H., Lacassin, F., Noël, B., Axler, O., Phelippeau, G., Braunstein, C., Marijon, É., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.243 · Cited by 12
Self-citationCalzado, S., Meneses, M. H., Llopis, J., Boix-Palop, L., Dietl, B., Calbo, E., Andrés, M., García, X., Agusti, C. R., Dorca, E., et al. (2023) · Surgery · doi:10.1016/j.surg.2023.04.061 · Cited by 11
Virulence of beta-hemolytic streptococci in infective endocarditis
Ruch, Y., Hansmann, Y., Riegel, P., Lefèbvre, N., Mazzucotelli, J., Douiri, N., Martin, A., & Argemi, X. (2019) · Infection · doi:10.1007/s15010-019-01358-7 · Cited by 11
Borde, J., Sitaru, G., Kopp, W. H., Ruhparwar, A., Ehlermann, P., Lasitschka, F., Dalpke, A. H., & Heininger, A. (2016) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-016-0505-0 · Cited by 11
“In-hospital mortality ranges from 15 to 22 %, and overall 5-year mortality is approximately 40 % [3–5].”
BackgroundMultimodality Imaging in Infective Endocarditis: A Clinical Approach to Diagnosis
Brugiatelli, L., Patani, F., Lofiego, C., Benedetti, M., Capodaglio, I., Giulia, P., Francioni, M., Paolini, E. A., Marco, N., Maurizi, K., et al. (2025) · Medicina · doi:10.3390/medicina61122241 · Cited by 11
Pollari, F., Spadaccio, C., Cuomo, M., Chello, M., Nenna, A., Fischlein, T. J. M., & Nappi, F. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-4626 · Cited by 11
“Localization of abscess is crucial to guide surgery (21,22).”
BackgroundInfluence of the healthcare pathway on the outcome of patients with infective endocarditis
Arregle, F., Iline, N., Giorgi, R., Philip, M., Hubert, S., Gouriet, F., Casalta, J., Collart, F., Ribéri, A., Martel, H., et al. (2022) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuac088 · Cited by 11
Fauchier, L., Pericart, L., Bourguignon, T., Genet, T., Bisson, A., Bernard, A. B., Bernard, L., & Babuty, D. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.07.100 · Cited by 11
Infective endocarditis in the Pacific: clinical characteristics, treatment and long-term outcomes
Mirabel, M., André, R., Mikhaïl, P. B., Colboc, H., Lacassin, F., Noël, B., Robert, J., Nadra, M., Braunstein, C., Gervolino, S., et al. (2015) · Open Heart · doi:10.1136/openhrt-2014-000183 · Cited by 11
“Our patients are younger by 10 years when compared to a recent survey conducted in France.2 In the USA, patients with IE are increasingly older; 36% of patients are over 69 years of age.3 As in Europe and North America, the most frequent pathogen in IE was S. aureus.1–3 However, S. viridans remains the second leading…”
ResultInfluentialSelf-citationCloître, A., Lesclous, P., Trochu, Q., Selton‐Suty, C., Boutoille, D., Tourneau, T. L., Delahaye, F., Thomas, D., Iung, B., Gaudin, A., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.07.042 · Cited by 11
“A causal link between IE and the oral cavity has long been assumed, [2] stemming from bacteremia and particularly oral Streptococcus resulting from invasive dental procedures [3].”
BackgroundSelf-citationSurgical Treatment of the Mitral Valve
Goldstone, A. B., & Woo, Y.-P. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-24126-7.00080-6 · Cited by 11
Infective endocarditis: diagnostic difficulties
Чипигина, Н. С., Karpova, N. Y., Belova, M. V., & Savilov, N. P. (2020) · The Clinician · doi:10.17650/1818-8338-2020-14-1-2-82-90 · Cited by 11
Strengths and limitations of patient registries in infective endocarditis
Escolà‐Vergé, L., Ribera, A., González, I. F., Pericàs, J. M., & Fernández‐Hidalgo, N. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.11.023 · Cited by 11
Dingen, H., Jordal, S., Bratt, S., Aukrust, P., Busund, R., Jakobsen, Ø. M., Dalén, M., Ueland, T., Svenarud, P. K., Haaverstad, R., et al. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09782-3 · Cited by 10
Adesomo, A. A., Gonzalez-Brown, V. M., & Rood, K. M. (2020) · American Journal of Perinatology Reports · doi:10.1055/s-0040-1716732 · Cited by 10
Workup and Management of Native and Prosthetic Valve Endocarditis
Abdulhak, A. A. B., Qazi, A., & Tleyjeh, I. M. (2018) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-018-0668-1 · Cited by 10
Molecular Imaging of Valvular Diseases and Cardiac Device Infection
Tarkin, J. M., Chen, W., Dweck, M. R., & Dilsizian, V. (2023) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.122.014652 · Cited by 10
Infective endocarditis surgery timing
Llah, S. T., Sharif, S., Ullah, S., Sheikh, S. A., Shah, M. A., Shafi, O., & Dar, T. A. (2023) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2023.07.007 · Cited by 10
Blood Culture-Negative Endocarditis
Fournier, P., Watt, G., Newton, P. N., Lamas, C. D. C., Tattevin, P., & Raoult, D. (2016) · Springer eBooks · doi:10.1007/978-3-319-32432-6_18 · Cited by 10
“In Europe, the incidence of BCNE has been reported to be 9 % in France [ 23 ], 13 % in the United Kingdom [ 19 ], 14 % in Spain [ 21 ], 20 % in Japan [ 20 ], 24 % in Sweden [ 24 ] and 25 % in Italy [ 25 ].”
BackgroundSchwarz, C., Buchholz, R., Jawad, M., Hoesker, V., Terwesten-Solé, C., Kärst, U., Linsen, L., Vogl, T. J., Hoerr, V., Wildgruber, M., et al. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00485 · Cited by 10
Bourget, M., Pasquie, M., Charbonneau, H., & Bonnet, É. (2022) · Infection · doi:10.1007/s15010-021-01738-y · Cited by 10
Proteus mirabilis endocarditis
Albuquerque, I., Silva, A. R., Carreira, M., & Friões, F. (2019) · BMJ Case Reports · doi:10.1136/bcr-2019-230575 · Cited by 10
Aortic vascular graft infection caused by Cardiobacterium valvarum: A case report
Hagiya, H., Kokeguchi, S., Ogawa, H., Terasaka, T., Kimura, K., Waseda, K., Hanayama, Y., Oda, K., Mori, H., Miyoshi, T., et al. (2014) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2014.07.008 · Cited by 10
Halavaara, M., Martelius, T., Anttila, V., & Järvinen, A. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa334 · Cited by 10
Zhang, W., Ju, P., Liu, X., Zhou, H., & Xue, F. (2020) · Journal of International Medical Research · doi:10.1177/0300060520940435 · Cited by 10
Drożdż, K., Gołda‐Cępa, M., & Brzychczy‐Włoch, M. (2024) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.2478/am-2024-0018 · Cited by 10
Delahaye, F., & de Gévigney, G. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.04.006 · Cited by 10
Self-citationBürgler, H., Gregoriano, C., Laager, R., Müeller, B., Schüetz, P., Conen, A., & Kutz, A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae582 · Cited by 10
Namini, Y. N., Heidarzadeh, S., Khaledi, A., Abbasi, E., Abbasi, A., & Esmaeili, D. (2019) · Malaysian Journal of Microbiology · doi:10.21161/mjm.180295 · Cited by 10
“…coccus in the nose (20-50% of people carrying the S. aureus in their nose) and the skin of healthy people in different proportions, and can be pathogenic in people who their body resistance due to the reasons has been reduced, can virulent and caused acute infection (Selton-Suty et al., 2012).”
BackgroundINFECTIVE ENDOCARDITIS IN ELDERLY: FROM ETIOLOGY TO TREATMENT AND PREVENTION
Ватутин, Н. Т., Тарадин, Г. Г., Chaus, E. A., & Смирнова, А. С. (2016) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2016-1-80-89 · Cited by 9
Wang, Q., Qiu, J., Huang, J.-L., Jiang, M., Lu, J.-Q., Wu, D., Wei, X., & Yu, D.-Q. (2023) · Infectious Diseases and Therapy · doi:10.1007/s40121-023-00867-1 · Cited by 9
Surgical Treatment of Active Endocarditis Pre- and Post-COVID-19 Pandemic Onset
Mikus, E., Fiorentino, M., Sangiorgi, D., Fiaschini, C., Tenti, E., Tremoli, E., Calvi, S., Costantino, A., Tripodi, A. G., Zucchetta, F., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12010233 · Cited by 9
“…disease decreased with a concomitant increase in infective endocarditis occurring in the elderly population or in patients presenting with new risk factors including intracardiac or intravenous devices, immunosuppressive conditions such as diabetes, hemodialysis, or intravenous drug use [3–8].”
BackgroundInfective Endocarditis After Invasive Medical and Surgical Procedures
Thornhill, M. H., Dayer, M., & Cahill, T. J. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.533 · Cited by 9
“(1-3) It is increasingly acquired in the healthcare setting, with at least 25% of cases occurring after a hospital or outpatient medical exposure.(4) In parallel, nosocomial staphylococci have replaced oral streptococci as the most common causative pathogen.”
BackgroundFillâtre, P., Gacouin, A., Revest, M., Maamar, A., Patrat-Delon, S., Flecher, E. M., Fouquet, O., Lerolle, N., Verhoye, J. P., Tulzo, Y. L., et al. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03764-z · Cited by 9
Self-citationRagnarsson, S., Sjögren, J. L., Stagmo, M., Wierup, P. N., & Nozohoor, S. (2015) · Journal of Cardiac Surgery · doi:10.1111/jocs.12591 · Cited by 9
“In the current study, the preoperative clinical presentation independently predicted the long-term survival following surgery for isolated nativemitral valve IE.”
BackgroundInfluentialLearning From Controversy: Contemporary Surgical Management of Aortic Valve Endocarditis
Nappi, F., Singh, S. S. A., & Timofeeva, I. (2020) · Clinical Medicine Insights Cardiology · doi:10.1177/1179546820960729 · Cited by 9
Yamashita, S., Tokushima, M., Nakashima, T., Katsuki, N. E., Tago, M., & Yamashita, S. (2020) · Internal Medicine · doi:10.2169/internalmedicine.4159-19 · Cited by 9
Schulte, J., Maurer, A., Domogalla, L.-C., Steinacker, N., Wadle, C., Kinzler, J., Eder, M., Mühlen, C. V. Z., Krohn-Grimberghe, M., & Eder, A.-C. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae547 · Cited by 9
“As PVE accounts for 20%–30% of IE cases and its incidence is increasing, future studies should continue to investigate 2-[ 18 F]F-PABA PET imaging in prosthetic infections, especially PVE [8, 33, 34].”
Jussli-Melchers, J., Salem, M., Schoettler, J., Friedrich, C., Huenges, K., Elke, G., Puehler, T., Cremer, J., & Haneya, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226693 · Cited by 9
“Up to 25% of IE cases are deemed to be healthcare-acquired [5].”
BackgroundSex-Based Differences in One-Year Outcomes After Mitral Valve Repair for Infective Endocarditis
Afshar, Z. M., Sabzi, F., Shirvani, M., Salehi, N., Nemati, N., Kheradmand, W., Torbati, H., & Rouzbahani, M. (2023) · Brazilian Journal of Cardiovascular Surgery · doi:10.21470/1678-9741-2021-0333 · Cited by 9
“Overall, these organisms account for 80–90% of all endocarditis cases[3].”
BackgroundHaemodialysis is a major risk factor for infective endocarditis
Labriola, L., & Jadoul, M. Y. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31105-9 · Cited by 9
Unexpected Infective Endocarditis: Towards a New Alert for Clinicians
Canna, G. L., Torracca, L., Barbone, A., & Scarfò, I. S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175058 · Cited by 8
Value of diagnosing immunological phenomena in patients with suspected endocarditis
van der Vaart, T. W., Heerschop, L. L., Bouma, B. J., Graaf, W. F.-D., Bonten, M. J. M., Prins, J. M., & van der Meer, J. T. M. (2022) · Infection · doi:10.1007/s15010-022-01954-0 · Cited by 8
“Since the development of the Duke Criteria, the epidemiology of IE has changed, with higher prevalence of prosthetic cardiac material and electronic devices, an ageing patient population and increasing predominance of staphylococcal endocarditis [5, 6].”
BackgroundImpact of the initial clinical presentation on the outcome of patients with infective endocarditis
Motoc, A. I., Kessels, J. I., Roosens, B., Lacor, P., de Veire, N. V., SUTTER, J. D., Magné, J., Droogmans, S., & Cosyns, B. (2023) · Cardiology Journal · doi:10.5603/cj.a2021.0075 · Cited by 8
“aureus has been identified as a predictor of in-hospital mortality, but no distinction between MRSA and Methicillin-susceptible Staphylococcus aureus (MSSA) was made [5, 7, 8, 11].”
BackgroundResultRasigade, J., Leclère, A., Alla, F., Tessier, A., Bes, M., Lechiche, C., Vernet-Garnier, V., Laouenan, C., Vandenesch, F., Leport, C., et al. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00187 · Cited by 8
“Staphylococcus aureus, the major causative agent of IE (Selton-Suty et al., 2012), induces severe forms that cause patient death twice as frequently as other microorganisms (Miro et al., 2005; Thuny et al., 2005, 2007).”
BackgroundMethodResultSelf-citationAcıbuca, A., Yılmaz, M., Okar, S., Kurşun, E., Acilar, O., Tekin, A., Demiroğlu, Y. Z., & Müderrisoğlu, H. (2021) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2021-009 · Cited by 8
“Recently there have been some changes in the epidemiology of IE worldwide, with Staphylococcus aureus and coagulasenegative staphylococci replacing streptococci as the causative micro-organisms.(2) When the underlying predisposing factors were reviewed, a decrease was seen in the prevalence of rheumatic heart disease…”
BackgroundExploring the Risk Factors and Possible Role of Calcium in Infective Endocarditis
Kuo, Y., & Tsai, Y.-M. (2023) · Diagnostics · doi:10.3390/diagnostics13142386 · Cited by 8
Is Infective Endocarditis Changing Over Time?
Delahaye, F., & Duclos, A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.016 · Cited by 8
“Health care–acquired IE (nosocomial or hospital-acquired IE and non-nosocomial or outpatient-acquired IE) accounted for 25% to 30% of IE cases in reported series (19,20).”
BackgroundSelf-citationEvaluation and Prevention of Cardioembolic Stroke
Kim, A. S. (2014) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000446103.82420.2d · Cited by 8
“Staphylococcus aureus, Streptococcus viridans, and Enterococcus are the most common organisms.(26) Endocarditis is suggested by fever, weight loss, a history of IV drug use or other source of bacteremia, a new murmur on physical examination, or evidence of systemic embolization to other vascular territories.”
BackgroundFranceschi, G., Soffritti, A., Mantovani, M., Digaetano, M., Prandini, F., Sarti, M., Bedini, A., Meschiari, M., & Mussini, C. (2024) · Microorganisms · doi:10.3390/microorganisms12112201 · Cited by 8
Emergency Considerations of Infective Endocarditis
Philip, J., & Bond, M. C. (2022) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2022.07.001 · Cited by 7
Pazderník, M., Kautzner, J., SOCHMAN, J., Kettner, J., Vojáček, J., & Pelouch, R. (2016) · Biomedical Papers · doi:10.5507/bp.2015.062 · Cited by 7
Mougeot, J.-L., Beckman, M. F., Paster, B. J., Lockhart, P. B., & Mougeot, F. B. (2022) · Journal of Oral Microbiology · doi:10.1080/20002297.2022.2144614 · Cited by 7
Candida tropicalis defibrillator endocarditis: A case report and review of current literature
Bauer, B. K., Schulze, A. B., Löher, A., Reinke, F., & Eckardt, L. (2019) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2019.06.001 · Cited by 7
Muthiah, A., Beitnes, J. O., & Skulstad, H. (2020) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2020.1734232 · Cited by 7
Menegüeti, M. G., Viana, J. M., Gaspar, G. G., Nicolini, E. A., Basile-Filho, A., & Auxiliadora‐Martins, M. (2016) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2703w · Cited by 7
New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended
Oliva, A., Dezza, F. C., Cancelli, F., Curtolo, A., Falletta, A., Volpicelli, L., & Venditti, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12247693 · Cited by 7
“Among them, Gram-positive staphylococci, streptococci, and enterococci represent 80–90% of all IE causes [3].”
BackgroundGaiser, M., Kirsch, J., & Mutzbauer, T. S. (2020) · Journal of Medical Internet Research · doi:10.2196/15304 · Cited by 7
“With an incidence of 3-7 cases per 100,000 people, infectious endocarditis is a rare but serious disease with a mortality rate of 20%-25% [46-50].”
BackgroundJCS 2026 Guideline on the Management of Infective Endocarditis
Izumi, C., Daimon, M., Kaji, S., Masumoto, A., Ashihara, K., Amano, M., Uemura, S., Ota, H., Ohara, T., Okada, K., et al. (2026) · Circulation Journal · doi:10.1253/circj.cj-25-0987 · Cited by 7
Goehringer, F., Soudant, M., Alauzet, C., Selton‐Suty, C., Agrinier, N., Virion, J., Lefèvre, B., Aissa, N., Alla, F., Ruch, Y., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf163 · Cited by 7
Self-citationCase report: Aorto-left atrial fistula—A rare complication of native aortic valve endocarditis
Saadia, S., Sultan, F. A. T., Iqbal, S., Fatimi, S. H., & Nasir, A. (2023) · The Egyptian Heart Journal · doi:10.1186/s43044-023-00384-z · Cited by 7
“4 cases per million in some parts of the world [1, 2].”
BackgroundTamzali, Y., Danthu, C., Aubry, A., Brousse, R., Faucher, J., Ouafi, Z. E., Rufat, P., Essig, M., Barrou, B., Touré, F., et al. (2021) · Pathogens · doi:10.3390/pathogens10081023 · Cited by 7
“IE in KTRs occurred mostly in younger people than in the general population [1,6,7,11], and on hearts without any IE-predisposing conditions, as in the general population [14].”
BackgroundInfective endocarditis in patients with hepatic diseases
Seminari, E. M., SILVESTRI, A. D., Ravasio, V., Ludovisi, S., Utili, R., Petrosillo, N., Castelli, F., Bassetti, M., Barbaro, F., Grossi, P., et al. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2541-4 · Cited by 7
A complication of meningitis and infective endocarditis due to Streptococcus pyogenes
Inoue, K., Hagiwara, A., Kimura, A., & Ohmagari, N. (2017) · BMJ Case Reports · doi:10.1136/bcr-2017-220847 · Cited by 7
Asai, N., Sakanashi, D., Suematsu, H., Nishiyama, N., Watanabe, H., Kato, H., Shiota, A., Hagihara, M., Koizumi, Y., Yamagishi, Y., et al. (2019) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2019.02.002 · Cited by 7
Ramadan, M., Stewart, V., Elsherif, N., Milligan, R., Beresford, A., & Marley, J. J. (2023) · BDJ · doi:10.1038/s41415-023-5796-7 · Cited by 7
“• Atrial fibrillation (4) • Cannula infection • Cardiac arrest • Catheter infection • Chest infection (2) • COVID-19 • Groin cellulitis • Haematuria • Hypokalaemia • Hyponatraemia • Liver function test disruption (3) • Pericardial effusion • Pneumonia • Pneumothorax • Seizure • Sepsis (Serratia marcescens) • Sternal w…”
BackgroundStaphylococcus aureus Endocarditis Immunothrombosis
Nappi, F. (2025) · Metabolites · doi:10.3390/metabo15050328 · Cited by 6
Gupta, R., Kaushal, V., Goyal, A., Kumar, P., Gupta, D., Tandon, R., Mahajan, A., Singla, S., Singh, G., Singh, B., et al. (2021) · Indian Heart Journal · doi:10.1016/j.ihj.2021.10.013 · Cited by 6
Lin, A., Kyaw, H., Lin, K., Pendharkar, S. S., Shaikh, A. Z., Ayala-Rodriguez, C. E., Abboud, J. A., & Reddy, S. (2019) · Cureus · doi:10.7759/cureus.3910 · Cited by 6
Sousa, C., Ribeiro, R. M., & Pinto, F. J. (2021) · Acta Médica Portuguesa · doi:10.20344/amp.14609 · Cited by 6
Sollini, M., Bartoli, F., Zanca, R., Enrica, E., Lazzeri, E., Slart, R. H. J. A., & Erba, P. A. (2022) · Springer eBooks · doi:10.1007/978-3-031-09807-9_12 · Cited by 6
Tala-Ighil, T., Royer, G., Lepeule, R., Fihman, V., Galy, A., Lim, P., Rodriguez, C., Jacquier, H., & Woerther, P. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf115 · Cited by 6
Mokoko, P., Cupido, B. J., Hitzeroth, J., Chin, A., & Ntsekhe, M. (2022) · South African Medical Journal · doi:10.7196/samj.2022.v112i4.16146 · Cited by 6
“[1] The IE-related in-hospital mortality rate is reported to be as high as 22% and the 5-year mortality rate up to 45%.[2-4] The mortality rate has remained stable despite advances in healthcare.”
BackgroundEndocarditis infecciosa en Hospital de Talca, período 1998 - 2015
Cruz, J., Marín, P., & Migueles, D. (2018) · Revista chilena de cardiología · doi:10.4067/s0718-85602018000100026 · Cited by 6
Infectious Endocarditis Prophylaxis in Children
Martin, J. P., & Lindgren, C. (2018) · Pediatric Emergency Care · doi:10.1097/pec.0000000000001628 · Cited by 6
Özlük, Ö. A., Akdeniz, A., Güçlü, E., Tuncay, B., & Bozat, T. (2020) · International Journal of Immunology · doi:10.11648/j.iji.20200801.12 · Cited by 6
“It is difficult to determine the exact incidence of IE worldwide, as the incidence numbers vary across countries [2, 3].”
BackgroundRisk Factors and Patient Profile of Infective Endocarditis due to Gemella spp.
Kariyanna, P. T., Sutarjono, B., Ellanti, N. P., Jayarangaiah, A., Jayarangaiah, A., Chandrakumar, H. P., Tadayoni, A., Salifu, M. O., & McFarlane, I. M. (2020) · American Journal of Medical Case Reports · doi:10.12691/ajmcr-9-2-4 · Cited by 6
“[1,2,3,4] Recognizing infective endocarditis is difficult due to the non-specific symptoms, such as sepsis of unknown origin or fevers without recognizing the risk factors.”
BackgroundInfective endocarditis prophylaxis: a review
Njuguna, B., & Delahaye, F. (2017) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2017.1281743 · Cited by 6
“A general focus on incidence or hospitalization of all cause IE in some studies [35,41,43] may not be adequately reflective as most prophylactic antibiotic regimens targeted oral streptococci (VGS) and not organisms like Staphylococcus aureus which are rising and leading causes of IE [4,44].”
BackgroundSelf-citationPilmis, B., Mizrahi, A., Laincer, A., Couzigou, C., Helali, N. E., Van, J. N., Abassade, P., Cador, R., & Monnier, A. L. (2016) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2015.12.012 · Cited by 6
“8 ase patients/million patient-years in France [2].”
InfluentialÇalık, A. N., ÖZLÜK, F. Ö. A., Karataş, M. B., Çanga, Y., Eren, S., Ayhan, G., Akdeniz, A., Palice, A., Candemir, A., Akyüz, Ş., et al. (2021) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.55730/1300-0144.5332 · Cited by 6
CURRENT DATA ABOUT THE AETIOLOGY AND TREATMENT OF INFECTIVE ENDOCARDITIS
Zaha, D. C. (2022) · FARMACIA · doi:10.31925/farmacia.2022.5.8 · Cited by 6
Booth, A. L., Li, C. Q., Al‐Dossari, G. A., & Stevenson, H. L. (2017) · BMJ Case Reports · doi:10.1136/bcr-2017-220368 · Cited by 6
Maltohexaose-indocyanine green (MH-ICG) for near infrared imaging of endocarditis
Takemiya, K., Røise, J. J., He, M., Taing, C., Rodriguez, A. G., Murthy, N., Goodman, M. M., & Taylor, W. R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247673 · Cited by 6
“aureus is one of the most commonly observed pathogens in patients with IE [1, 2, 16, 17].”
BackgroundO que há de novo no tratamento da endocardite infecciosa: uma revisão integrativa
ALMEIDA, G. M. F. D., de Melo, P. L. C. E., Vieira, R. E. G., Silva, F. B. E., Gonçalves, J. R., Moreira, L. K. P., Fonseca, J. P., Bóis, R. V., Bóis, T. R. M. M., de Moura, A. C., et al. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n1-166 · Cited by 6
The impact of transoesophageal echocardiography in elderly patients with infective endocarditis
N'CHO-MOTTOH, M.-P. B., Erpelding, M., Baudron, C. R., Delahaye, F., Fraisse, T., Dijos, M., Ennezat, P.-V., Fluttaz, A., Richard, B., Beaufort, C., et al. (2023) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2023.04.001 · Cited by 6
Self-citationYamashita, S., Tago, M., Katsuki, N. E., Ajimi, T., Nagatomo, D., Kotooka, N., Node, K., & Yamashita, S. (2018) · American Journal of Case Reports · doi:10.12659/ajcr.912097 · Cited by 6
Graversen, P. L., Østergaard, L., Voldstedlund, M., Wandall‐Holm, M. F., Smerup, M., Køber, L., & Fosbøl, E. L. (2023) · Microorganisms · doi:10.3390/microorganisms11102403 · Cited by 5
Chen, Y., Ren, J., Li, F., Ye, X., & Wu, Y. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10157-x · Cited by 5
Escherichia coli endocarditis in an hemodialysis patient
Vieille, T., Winiszewski, H., Chirouze, C., Bertrand, X., & Fournier, P. (2019) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2019.03.004 · Cited by 5
Self-citationInfective Endocarditis: A Case Series
Singh, S. P., & Singh, D. (2020) · Journal of Cardiac Critical Care TSS · doi:10.1055/s-0040-1716610 · Cited by 5
Celestin, B. E., Ilic-Habensus, E., Tubiana, S., Préau, M., Millot, S., Lescure, F.-X., Kerneis, C., Para, M., Duval, X., & Iung, B. (2023) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2023.01.003 · Cited by 5
Self-citationTan, R., Yu, J., Wang, J., & Zheng, R. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i29.10670 · Cited by 5
Metadata
- Authors
- Selton-Suty, C., Célard, M., Le Moing, V., Doco-Lecompte, T., Chirouze, C., Iung, B., Strady, C., Revest, M., Vandenesch, F., Bouvet, A., Delahaye, F., Alla, F., Duval, X., & Hoen, B.
- Affiliations
- Laboratoire Chrono-Environnement (FR)
- Hôpital Pontchaillou (FR)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Hôpital Bichat-Claude-Bernard (FR)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-05-01
- Volume
- 54
- Issue
- 9
- Pages
- 1230-1239
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2155794989
- Semantic Scholar
- 46e2ed77823a43f31fbb6342dfb12aabb30be85d
- Cited by
- 710
- References
- 29
- Citations by year
- 2026: 30 · 2025: 37 · 2024: 55 · 2023: 66 · 2022: 64 · 2021: 51 · 2020: 65 · 2019: 67 · 2018: 42 · 2017: 53 · 2016: 56 · 2015: 47 · 2014: 32 · 2013: 35 · 2012: 8
- FWCI
- 29.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- infective endocarditis, Staphylococcus aureus, coagulase-negative staphylococci, community-acquired endocarditis, incidence, in-hospital mortality, risk factors, referral bias
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Cross Infection, Endocarditis, Bacterial, Female, France, Hospitals, Humans, Male, Middle Aged, Population Surveillance, Prognosis, Risk Factors, Staphylococcal Infections, Staphylococcus, Staphylococcus aureus, Incidence, Community-Acquired Infections, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.